QUOTE AND NEWS
SeekingAlpha  7 hrs ago  Comment 
By SA Transcripts: Urologix, Inc. (NASDAQ:ULGX) Q4 2014 Results Earnings Conference Call August 19, 2014 5:00 PM ET Executives Greg Fluet - Chief Executive Officer Becky Weber - Controller and Director, Finance Analysts ...
SeekingAlpha  Feb 5  Comment 
Urologix Inc. (ULGX) F2Q 2014 Results Earnings Call February 4, 2014 5:00 PM ET Executives Greg Fluet - Chief Executive Officer Brian Smrdel - Chief Financial Officer Analysts Presentation Operator Good day,...
StreetInsider.com  May 1  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Urologix%2C+Inc.+%28ULGX%29+Tops+Q3+Views/8295295.html for the full story.
Benzinga  Apr 8  Comment 
Urologix, Inc. (Nasdaq: ULGX), the leading provider of in-office BPH therapy, today announced that it has reached an important milestone in its licensing agreement with Medtronic for the Prostiva RF Therapy System. In accordance with the terms of...
StreetInsider.com  Nov 14  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Urologix%2C+Inc.+%28ULGX%29+Posts+Q1+Loss+ot+5cShare/7878950.html for the full story.
StreetInsider.com  Aug 23  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Urologix%2C+Inc.+%28ULGX%29+Reports+Q4+Loss+of+%240.08%3B+Guides+FY13+Sales/7683048.html for the full story.
StreetInsider.com  Aug 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Urologix+%28ULGX%29+Closes+5.2M+Offering%2C+Full-Allotment+Exercised/7637860.html for the full story.
Globe Newswire  Jul 18  Comment 
MINNEAPOLIS, July 18, 2012 (GLOBE NEWSWIRE) -- Urologix®, Inc. (Nasdaq:ULGX), the leading provider of in-office procedures for the safe, durable and effective treatment of BPH, announced today it has received a letter of determination from The
Globe Newswire  Jul 5  Comment 
MINNEAPOLIS, July 5, 2012 (GLOBE NEWSWIRE) -- Urologix®, Inc. (Nasdaq:ULGX), the leading provider of in-office procedures for the safe, durable and effective treatment of BPH, today announced the closing of its previously announced follow-on firm
Globe Newswire  Jun 29  Comment 
MINNEAPOLIS, June 29, 2012 (GLOBE NEWSWIRE) -- Urologix®, Inc. (Nasdaq:ULGX), the leading provider of in-office procedures for the safe, durable and effective treatment of BPH, today announced the pricing of its registered follow-on firm commitment





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki